Actinomycetoma and advances in its treatment
- 8 June 2012
- journal article
- editorial
- Published by Elsevier in Clinics in Dermatology
- Vol. 30 (4) , 372-381
- https://doi.org/10.1016/j.clindermatol.2011.06.027
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophagesJournal of Antimicrobial Chemotherapy, 2009
- Emerging therapeutic regimes for the management of mycetomasExpert Opinion on Pharmacotherapy, 2008
- Efficacy of DA-7218, a New Oxazolidinone Prodrug, in the Treatment of Experimental Actinomycetoma Produced by Nocardia brasiliensisMolecules, 2008
- Treatment of actinomycetoma due to Nocardia spp. with amoxicillin?clavulanateBritish Journal of Dermatology, 2007
- In Vitro Activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensisAntimicrobial Agents and Chemotherapy, 2006
- In Vitro Activities of New Quinolones and Oxazolidinones against Actinomadura maduraeAntimicrobial Agents and Chemotherapy, 2004
- Polyphasic Taxonomic Study of Clinically Significant Actinomadurae Including the Description of Actinomadura latina sp. nov.Zentralblatt für Bakteriologie, 1997
- Immunity to Intracellular BacteriaAnnual Review of Immunology, 1993
- Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetomaJournal of the American Academy of Dermatology, 1987
- Imipenem/CilastatinDrugs, 1987